Global Cefuroxim Market Growth (Status and Outlook) 2025-2031

September 2025 | 177 pages | ID: GD26FE76F383EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global Cefuroxim market size will reach US$ million by 2031.

Cefuroxim

United States market for Cefuroxim is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cefuroxim is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cefuroxim is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cefuroxim players cover Apotex, Esseti Farmaceutici, GSK, Lilly, Medochemie, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cefuroxim Industry Forecast” looks at past sales and reviews total world Cefuroxim sales in 2024, providing a comprehensive analysis by region and market sector of projected Cefuroxim sales for 2025 through 2031. With Cefuroxim sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cefuroxim industry.

This Insight Report provides a comprehensive analysis of the global Cefuroxim landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cefuroxim portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cefuroxim market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cefuroxim and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cefuroxim.

This report presents a comprehensive overview, market shares, and growth opportunities of Cefuroxim market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Injection
  • Tablets
  • Capsule
Segmentation by Application:
  • Respiratory Tract Infection
  • Otolaryngological Infection
  • Urinary Tract Infection
  • Skin And Soft Tissue Infections
  • Bone And Joint Infections
  • Gonorrhea
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Apotex
  • Esseti Farmaceutici
  • GSK
  • Lilly
  • Medochemie
  • Northeast Pharmaceutical
  • NCPC
  • Nanchang Lijian Pharmaceutical
  • Sichuan Pharmaceutical
  • Shandong Runze Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Guangdong Bozhou Pharmaceutical
  • Guangdong Jincheng Jinsu Pharmaceutical
  • Guangzhou Baiyunshan Tianxin Pharmaceutical
  • Guangxi Kelun Pharmaceutical
  • Yuekang Pharmaceutical Group
  • Shantou Jinshi Injection
  • Zhejiang Yatai Pharmaceutical
  • Shenzhen Xinlitai Pharmaceutical
  • Shenzhen Huarun Jiuxin Pharmaceutical
  • Zhuhai Union Pharmaceutical
  • Ruiyang Pharmaceutical
  • Fujian Fukang Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • furen Pharmaceutical Group
  • Chongqing Kerui Pharmaceutical Group
  • Shaanxi Xidunsi Pharmaceutical
  • Qilu Pharmaceutical
  • Shandong Zibo Xinda Pharmaceutical
  • Guangzhou Nanxin Pharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cefuroxim Market Size (2020-2031)
  2.1.2 Cefuroxim Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cefuroxim by Country/Region (2020, 2024 & 2031)
2.2 Cefuroxim Segment by Type
  2.2.1 Injection
  2.2.2 Tablets
  2.2.3 Capsule
2.3 Cefuroxim Market Size by Type
  2.3.1 Cefuroxim Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cefuroxim Market Size Market Share by Type (2020-2025)
2.4 Cefuroxim Segment by Application
  2.4.1 Respiratory Tract Infection
  2.4.2 Otolaryngological Infection
  2.4.3 Urinary Tract Infection
  2.4.4 Skin And Soft Tissue Infections
  2.4.5 Bone And Joint Infections
  2.4.6 Gonorrhea
  2.4.7 Other
2.5 Cefuroxim Market Size by Application
  2.5.1 Cefuroxim Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cefuroxim Market Size Market Share by Application (2020-2025)

3 CEFUROXIM MARKET SIZE BY PLAYER

3.1 Cefuroxim Market Size Market Share by Player
  3.1.1 Global Cefuroxim Revenue by Player (2020-2025)
  3.1.2 Global Cefuroxim Revenue Market Share by Player (2020-2025)
3.2 Global Cefuroxim Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CEFUROXIM BY REGION

4.1 Cefuroxim Market Size by Region (2020-2025)
4.2 Global Cefuroxim Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cefuroxim Market Size Growth (2020-2025)
4.4 APAC Cefuroxim Market Size Growth (2020-2025)
4.5 Europe Cefuroxim Market Size Growth (2020-2025)
4.6 Middle East & Africa Cefuroxim Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cefuroxim Market Size by Country (2020-2025)
5.2 Americas Cefuroxim Market Size by Type (2020-2025)
5.3 Americas Cefuroxim Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cefuroxim Market Size by Region (2020-2025)
6.2 APAC Cefuroxim Market Size by Type (2020-2025)
6.3 APAC Cefuroxim Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cefuroxim Market Size by Country (2020-2025)
7.2 Europe Cefuroxim Market Size by Type (2020-2025)
7.3 Europe Cefuroxim Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cefuroxim by Region (2020-2025)
8.2 Middle East & Africa Cefuroxim Market Size by Type (2020-2025)
8.3 Middle East & Africa Cefuroxim Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CEFUROXIM MARKET FORECAST

10.1 Global Cefuroxim Forecast by Region (2026-2031)
  10.1.1 Global Cefuroxim Forecast by Region (2026-2031)
  10.1.2 Americas Cefuroxim Forecast
  10.1.3 APAC Cefuroxim Forecast
  10.1.4 Europe Cefuroxim Forecast
  10.1.5 Middle East & Africa Cefuroxim Forecast
10.2 Americas Cefuroxim Forecast by Country (2026-2031)
  10.2.1 United States Market Cefuroxim Forecast
  10.2.2 Canada Market Cefuroxim Forecast
  10.2.3 Mexico Market Cefuroxim Forecast
  10.2.4 Brazil Market Cefuroxim Forecast
10.3 APAC Cefuroxim Forecast by Region (2026-2031)
  10.3.1 China Cefuroxim Market Forecast
  10.3.2 Japan Market Cefuroxim Forecast
  10.3.3 Korea Market Cefuroxim Forecast
  10.3.4 Southeast Asia Market Cefuroxim Forecast
  10.3.5 India Market Cefuroxim Forecast
  10.3.6 Australia Market Cefuroxim Forecast
10.4 Europe Cefuroxim Forecast by Country (2026-2031)
  10.4.1 Germany Market Cefuroxim Forecast
  10.4.2 France Market Cefuroxim Forecast
  10.4.3 UK Market Cefuroxim Forecast
  10.4.4 Italy Market Cefuroxim Forecast
  10.4.5 Russia Market Cefuroxim Forecast
10.5 Middle East & Africa Cefuroxim Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cefuroxim Forecast
  10.5.2 South Africa Market Cefuroxim Forecast
  10.5.3 Israel Market Cefuroxim Forecast
  10.5.4 Turkey Market Cefuroxim Forecast
10.6 Global Cefuroxim Forecast by Type (2026-2031)
10.7 Global Cefuroxim Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cefuroxim Forecast

11 KEY PLAYERS ANALYSIS

11.1 Apotex
  11.1.1 Apotex Company Information
  11.1.2 Apotex Cefuroxim Product Offered
  11.1.3 Apotex Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Apotex Main Business Overview
  11.1.5 Apotex Latest Developments
11.2 Esseti Farmaceutici
  11.2.1 Esseti Farmaceutici Company Information
  11.2.2 Esseti Farmaceutici Cefuroxim Product Offered
  11.2.3 Esseti Farmaceutici Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Esseti Farmaceutici Main Business Overview
  11.2.5 Esseti Farmaceutici Latest Developments
11.3 GSK
  11.3.1 GSK Company Information
  11.3.2 GSK Cefuroxim Product Offered
  11.3.3 GSK Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 GSK Main Business Overview
  11.3.5 GSK Latest Developments
11.4 Lilly
  11.4.1 Lilly Company Information
  11.4.2 Lilly Cefuroxim Product Offered
  11.4.3 Lilly Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Lilly Main Business Overview
  11.4.5 Lilly Latest Developments
11.5 Medochemie
  11.5.1 Medochemie Company Information
  11.5.2 Medochemie Cefuroxim Product Offered
  11.5.3 Medochemie Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Medochemie Main Business Overview
  11.5.5 Medochemie Latest Developments
11.6 Northeast Pharmaceutical
  11.6.1 Northeast Pharmaceutical Company Information
  11.6.2 Northeast Pharmaceutical Cefuroxim Product Offered
  11.6.3 Northeast Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Northeast Pharmaceutical Main Business Overview
  11.6.5 Northeast Pharmaceutical Latest Developments
11.7 NCPC
  11.7.1 NCPC Company Information
  11.7.2 NCPC Cefuroxim Product Offered
  11.7.3 NCPC Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 NCPC Main Business Overview
  11.7.5 NCPC Latest Developments
11.8 Nanchang Lijian Pharmaceutical
  11.8.1 Nanchang Lijian Pharmaceutical Company Information
  11.8.2 Nanchang Lijian Pharmaceutical Cefuroxim Product Offered
  11.8.3 Nanchang Lijian Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Nanchang Lijian Pharmaceutical Main Business Overview
  11.8.5 Nanchang Lijian Pharmaceutical Latest Developments
11.9 Sichuan Pharmaceutical
  11.9.1 Sichuan Pharmaceutical Company Information
  11.9.2 Sichuan Pharmaceutical Cefuroxim Product Offered
  11.9.3 Sichuan Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sichuan Pharmaceutical Main Business Overview
  11.9.5 Sichuan Pharmaceutical Latest Developments
11.10 Shandong Runze Pharmaceutical
  11.10.1 Shandong Runze Pharmaceutical Company Information
  11.10.2 Shandong Runze Pharmaceutical Cefuroxim Product Offered
  11.10.3 Shandong Runze Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Shandong Runze Pharmaceutical Main Business Overview
  11.10.5 Shandong Runze Pharmaceutical Latest Developments
11.11 Shandong Luoxin Pharmaceutical Group
  11.11.1 Shandong Luoxin Pharmaceutical Group Company Information
  11.11.2 Shandong Luoxin Pharmaceutical Group Cefuroxim Product Offered
  11.11.3 Shandong Luoxin Pharmaceutical Group Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Shandong Luoxin Pharmaceutical Group Main Business Overview
  11.11.5 Shandong Luoxin Pharmaceutical Group Latest Developments
11.12 Guangdong Bozhou Pharmaceutical
  11.12.1 Guangdong Bozhou Pharmaceutical Company Information
  11.12.2 Guangdong Bozhou Pharmaceutical Cefuroxim Product Offered
  11.12.3 Guangdong Bozhou Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Guangdong Bozhou Pharmaceutical Main Business Overview
  11.12.5 Guangdong Bozhou Pharmaceutical Latest Developments
11.13 Guangdong Jincheng Jinsu Pharmaceutical
  11.13.1 Guangdong Jincheng Jinsu Pharmaceutical Company Information
  11.13.2 Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Product Offered
  11.13.3 Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Guangdong Jincheng Jinsu Pharmaceutical Main Business Overview
  11.13.5 Guangdong Jincheng Jinsu Pharmaceutical Latest Developments
11.14 Guangzhou Baiyunshan Tianxin Pharmaceutical
  11.14.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
  11.14.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Product Offered
  11.14.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Overview
  11.14.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
11.15 Guangxi Kelun Pharmaceutical
  11.15.1 Guangxi Kelun Pharmaceutical Company Information
  11.15.2 Guangxi Kelun Pharmaceutical Cefuroxim Product Offered
  11.15.3 Guangxi Kelun Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Guangxi Kelun Pharmaceutical Main Business Overview
  11.15.5 Guangxi Kelun Pharmaceutical Latest Developments
11.16 Yuekang Pharmaceutical Group
  11.16.1 Yuekang Pharmaceutical Group Company Information
  11.16.2 Yuekang Pharmaceutical Group Cefuroxim Product Offered
  11.16.3 Yuekang Pharmaceutical Group Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Yuekang Pharmaceutical Group Main Business Overview
  11.16.5 Yuekang Pharmaceutical Group Latest Developments
11.17 Shantou Jinshi Injection
  11.17.1 Shantou Jinshi Injection Company Information
  11.17.2 Shantou Jinshi Injection Cefuroxim Product Offered
  11.17.3 Shantou Jinshi Injection Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Shantou Jinshi Injection Main Business Overview
  11.17.5 Shantou Jinshi Injection Latest Developments
11.18 Zhejiang Yatai Pharmaceutical
  11.18.1 Zhejiang Yatai Pharmaceutical Company Information
  11.18.2 Zhejiang Yatai Pharmaceutical Cefuroxim Product Offered
  11.18.3 Zhejiang Yatai Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Zhejiang Yatai Pharmaceutical Main Business Overview
  11.18.5 Zhejiang Yatai Pharmaceutical Latest Developments
11.19 Shenzhen Xinlitai Pharmaceutical
  11.19.1 Shenzhen Xinlitai Pharmaceutical Company Information
  11.19.2 Shenzhen Xinlitai Pharmaceutical Cefuroxim Product Offered
  11.19.3 Shenzhen Xinlitai Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Shenzhen Xinlitai Pharmaceutical Main Business Overview
  11.19.5 Shenzhen Xinlitai Pharmaceutical Latest Developments
11.20 Shenzhen Huarun Jiuxin Pharmaceutical
  11.20.1 Shenzhen Huarun Jiuxin Pharmaceutical Company Information
  11.20.2 Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Product Offered
  11.20.3 Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Shenzhen Huarun Jiuxin Pharmaceutical Main Business Overview
  11.20.5 Shenzhen Huarun Jiuxin Pharmaceutical Latest Developments
11.21 Zhuhai Union Pharmaceutical
  11.21.1 Zhuhai Union Pharmaceutical Company Information
  11.21.2 Zhuhai Union Pharmaceutical Cefuroxim Product Offered
  11.21.3 Zhuhai Union Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.21.4 Zhuhai Union Pharmaceutical Main Business Overview
  11.21.5 Zhuhai Union Pharmaceutical Latest Developments
11.22 Ruiyang Pharmaceutical
  11.22.1 Ruiyang Pharmaceutical Company Information
  11.22.2 Ruiyang Pharmaceutical Cefuroxim Product Offered
  11.22.3 Ruiyang Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.22.4 Ruiyang Pharmaceutical Main Business Overview
  11.22.5 Ruiyang Pharmaceutical Latest Developments
11.23 Fujian Fukang Pharmaceutical
  11.23.1 Fujian Fukang Pharmaceutical Company Information
  11.23.2 Fujian Fukang Pharmaceutical Cefuroxim Product Offered
  11.23.3 Fujian Fukang Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.23.4 Fujian Fukang Pharmaceutical Main Business Overview
  11.23.5 Fujian Fukang Pharmaceutical Latest Developments
11.24 Suzhou Erye Pharmaceutical
  11.24.1 Suzhou Erye Pharmaceutical Company Information
  11.24.2 Suzhou Erye Pharmaceutical Cefuroxim Product Offered
  11.24.3 Suzhou Erye Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.24.4 Suzhou Erye Pharmaceutical Main Business Overview
  11.24.5 Suzhou Erye Pharmaceutical Latest Developments
11.25 furen Pharmaceutical Group
  11.25.1 furen Pharmaceutical Group Company Information
  11.25.2 furen Pharmaceutical Group Cefuroxim Product Offered
  11.25.3 furen Pharmaceutical Group Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.25.4 furen Pharmaceutical Group Main Business Overview
  11.25.5 furen Pharmaceutical Group Latest Developments
11.26 Chongqing Kerui Pharmaceutical Group
  11.26.1 Chongqing Kerui Pharmaceutical Group Company Information
  11.26.2 Chongqing Kerui Pharmaceutical Group Cefuroxim Product Offered
  11.26.3 Chongqing Kerui Pharmaceutical Group Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.26.4 Chongqing Kerui Pharmaceutical Group Main Business Overview
  11.26.5 Chongqing Kerui Pharmaceutical Group Latest Developments
11.27 Shaanxi Xidunsi Pharmaceutical
  11.27.1 Shaanxi Xidunsi Pharmaceutical Company Information
  11.27.2 Shaanxi Xidunsi Pharmaceutical Cefuroxim Product Offered
  11.27.3 Shaanxi Xidunsi Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.27.4 Shaanxi Xidunsi Pharmaceutical Main Business Overview
  11.27.5 Shaanxi Xidunsi Pharmaceutical Latest Developments
11.28 Qilu Pharmaceutical
  11.28.1 Qilu Pharmaceutical Company Information
  11.28.2 Qilu Pharmaceutical Cefuroxim Product Offered
  11.28.3 Qilu Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.28.4 Qilu Pharmaceutical Main Business Overview
  11.28.5 Qilu Pharmaceutical Latest Developments
11.29 Shandong Zibo Xinda Pharmaceutical
  11.29.1 Shandong Zibo Xinda Pharmaceutical Company Information
  11.29.2 Shandong Zibo Xinda Pharmaceutical Cefuroxim Product Offered
  11.29.3 Shandong Zibo Xinda Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.29.4 Shandong Zibo Xinda Pharmaceutical Main Business Overview
  11.29.5 Shandong Zibo Xinda Pharmaceutical Latest Developments
11.30 Guangzhou Nanxin Pharmaceutical
  11.30.1 Guangzhou Nanxin Pharmaceutical Company Information
  11.30.2 Guangzhou Nanxin Pharmaceutical Cefuroxim Product Offered
  11.30.3 Guangzhou Nanxin Pharmaceutical Cefuroxim Revenue, Gross Margin and Market Share (2020-2025)
  11.30.4 Guangzhou Nanxin Pharmaceutical Main Business Overview
  11.30.5 Guangzhou Nanxin Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Cefuroxim Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cefuroxim Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofTablets
Table 5. Major Players of Capsule
Table 6. Cefuroxim Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Cefuroxim Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Cefuroxim Market Size Market Share by Type (2020-2025)
Table 9. Cefuroxim Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Cefuroxim Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Cefuroxim Market Size Market Share by Application (2020-2025)
Table 12. Global Cefuroxim Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Cefuroxim Revenue Market Share by Player (2020-2025)
Table 14. Cefuroxim Key Players Head office and Products Offered
Table 15. Cefuroxim Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cefuroxim Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Cefuroxim Market Size Market Share by Region (2020-2025)
Table 20. Global Cefuroxim Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Cefuroxim Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Cefuroxim Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Cefuroxim Market Size Market Share by Country (2020-2025)
Table 24. Americas Cefuroxim Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Cefuroxim Market Size Market Share by Type (2020-2025)
Table 26. Americas Cefuroxim Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Cefuroxim Market Size Market Share by Application (2020-2025)
Table 28. APAC Cefuroxim Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Cefuroxim Market Size Market Share by Region (2020-2025)
Table 30. APAC Cefuroxim Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Cefuroxim Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Cefuroxim Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Cefuroxim Market Size Market Share by Country (2020-2025)
Table 34. Europe Cefuroxim Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Cefuroxim Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cefuroxim Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cefuroxim Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Cefuroxim Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cefuroxim
Table 40. Key Market Challenges & Risks of Cefuroxim
Table 41. Key Industry Trends of Cefuroxim
Table 42. Global Cefuroxim Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Cefuroxim Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Cefuroxim Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Cefuroxim Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Apotex Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 47. Apotex Cefuroxim Product Offered
Table 48. Apotex Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Apotex Main Business
Table 50. Apotex Latest Developments
Table 51. Esseti Farmaceutici Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 52. Esseti Farmaceutici Cefuroxim Product Offered
Table 53. Esseti Farmaceutici Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Esseti Farmaceutici Main Business
Table 55. Esseti Farmaceutici Latest Developments
Table 56. GSK Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 57. GSK Cefuroxim Product Offered
Table 58. GSK Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GSK Main Business
Table 60. GSK Latest Developments
Table 61. Lilly Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 62. Lilly Cefuroxim Product Offered
Table 63. Lilly Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Lilly Main Business
Table 65. Lilly Latest Developments
Table 66. Medochemie Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 67. Medochemie Cefuroxim Product Offered
Table 68. Medochemie Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Medochemie Main Business
Table 70. Medochemie Latest Developments
Table 71. Northeast Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 72. Northeast Pharmaceutical Cefuroxim Product Offered
Table 73. Northeast Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Northeast Pharmaceutical Main Business
Table 75. Northeast Pharmaceutical Latest Developments
Table 76. NCPC Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 77. NCPC Cefuroxim Product Offered
Table 78. NCPC Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. NCPC Main Business
Table 80. NCPC Latest Developments
Table 81. Nanchang Lijian Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 82. Nanchang Lijian Pharmaceutical Cefuroxim Product Offered
Table 83. Nanchang Lijian Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Nanchang Lijian Pharmaceutical Main Business
Table 85. Nanchang Lijian Pharmaceutical Latest Developments
Table 86. Sichuan Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 87. Sichuan Pharmaceutical Cefuroxim Product Offered
Table 88. Sichuan Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Sichuan Pharmaceutical Main Business
Table 90. Sichuan Pharmaceutical Latest Developments
Table 91. Shandong Runze Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 92. Shandong Runze Pharmaceutical Cefuroxim Product Offered
Table 93. Shandong Runze Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Shandong Runze Pharmaceutical Main Business
Table 95. Shandong Runze Pharmaceutical Latest Developments
Table 96. Shandong Luoxin Pharmaceutical Group Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 97. Shandong Luoxin Pharmaceutical Group Cefuroxim Product Offered
Table 98. Shandong Luoxin Pharmaceutical Group Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Shandong Luoxin Pharmaceutical Group Main Business
Table 100. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 101. Guangdong Bozhou Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 102. Guangdong Bozhou Pharmaceutical Cefuroxim Product Offered
Table 103. Guangdong Bozhou Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Guangdong Bozhou Pharmaceutical Main Business
Table 105. Guangdong Bozhou Pharmaceutical Latest Developments
Table 106. Guangdong Jincheng Jinsu Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 107. Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Product Offered
Table 108. Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Guangdong Jincheng Jinsu Pharmaceutical Main Business
Table 110. Guangdong Jincheng Jinsu Pharmaceutical Latest Developments
Table 111. Guangzhou Baiyunshan Tianxin Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 112. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Product Offered
Table 113. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business
Table 115. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
Table 116. Guangxi Kelun Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 117. Guangxi Kelun Pharmaceutical Cefuroxim Product Offered
Table 118. Guangxi Kelun Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Guangxi Kelun Pharmaceutical Main Business
Table 120. Guangxi Kelun Pharmaceutical Latest Developments
Table 121. Yuekang Pharmaceutical Group Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 122. Yuekang Pharmaceutical Group Cefuroxim Product Offered
Table 123. Yuekang Pharmaceutical Group Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Yuekang Pharmaceutical Group Main Business
Table 125. Yuekang Pharmaceutical Group Latest Developments
Table 126. Shantou Jinshi Injection Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 127. Shantou Jinshi Injection Cefuroxim Product Offered
Table 128. Shantou Jinshi Injection Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Shantou Jinshi Injection Main Business
Table 130. Shantou Jinshi Injection Latest Developments
Table 131. Zhejiang Yatai Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 132. Zhejiang Yatai Pharmaceutical Cefuroxim Product Offered
Table 133. Zhejiang Yatai Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Zhejiang Yatai Pharmaceutical Main Business
Table 135. Zhejiang Yatai Pharmaceutical Latest Developments
Table 136. Shenzhen Xinlitai Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 137. Shenzhen Xinlitai Pharmaceutical Cefuroxim Product Offered
Table 138. Shenzhen Xinlitai Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Shenzhen Xinlitai Pharmaceutical Main Business
Table 140. Shenzhen Xinlitai Pharmaceutical Latest Developments
Table 141. Shenzhen Huarun Jiuxin Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 142. Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Product Offered
Table 143. Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Shenzhen Huarun Jiuxin Pharmaceutical Main Business
Table 145. Shenzhen Huarun Jiuxin Pharmaceutical Latest Developments
Table 146. Zhuhai Union Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 147. Zhuhai Union Pharmaceutical Cefuroxim Product Offered
Table 148. Zhuhai Union Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 149. Zhuhai Union Pharmaceutical Main Business
Table 150. Zhuhai Union Pharmaceutical Latest Developments
Table 151. Ruiyang Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 152. Ruiyang Pharmaceutical Cefuroxim Product Offered
Table 153. Ruiyang Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 154. Ruiyang Pharmaceutical Main Business
Table 155. Ruiyang Pharmaceutical Latest Developments
Table 156. Fujian Fukang Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 157. Fujian Fukang Pharmaceutical Cefuroxim Product Offered
Table 158. Fujian Fukang Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 159. Fujian Fukang Pharmaceutical Main Business
Table 160. Fujian Fukang Pharmaceutical Latest Developments
Table 161. Suzhou Erye Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 162. Suzhou Erye Pharmaceutical Cefuroxim Product Offered
Table 163. Suzhou Erye Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 164. Suzhou Erye Pharmaceutical Main Business
Table 165. Suzhou Erye Pharmaceutical Latest Developments
Table 166. furen Pharmaceutical Group Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 167. furen Pharmaceutical Group Cefuroxim Product Offered
Table 168. furen Pharmaceutical Group Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 169. furen Pharmaceutical Group Main Business
Table 170. furen Pharmaceutical Group Latest Developments
Table 171. Chongqing Kerui Pharmaceutical Group Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 172. Chongqing Kerui Pharmaceutical Group Cefuroxim Product Offered
Table 173. Chongqing Kerui Pharmaceutical Group Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 174. Chongqing Kerui Pharmaceutical Group Main Business
Table 175. Chongqing Kerui Pharmaceutical Group Latest Developments
Table 176. Shaanxi Xidunsi Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 177. Shaanxi Xidunsi Pharmaceutical Cefuroxim Product Offered
Table 178. Shaanxi Xidunsi Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 179. Shaanxi Xidunsi Pharmaceutical Main Business
Table 180. Shaanxi Xidunsi Pharmaceutical Latest Developments
Table 181. Qilu Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 182. Qilu Pharmaceutical Cefuroxim Product Offered
Table 183. Qilu Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 184. Qilu Pharmaceutical Main Business
Table 185. Qilu Pharmaceutical Latest Developments
Table 186. Shandong Zibo Xinda Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 187. Shandong Zibo Xinda Pharmaceutical Cefuroxim Product Offered
Table 188. Shandong Zibo Xinda Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 189. Shandong Zibo Xinda Pharmaceutical Main Business
Table 190. Shandong Zibo Xinda Pharmaceutical Latest Developments
Table 191. Guangzhou Nanxin Pharmaceutical Details, Company Type, Cefuroxim Area Served and Its Competitors
Table 192. Guangzhou Nanxin Pharmaceutical Cefuroxim Product Offered
Table 193. Guangzhou Nanxin Pharmaceutical Cefuroxim Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 194. Guangzhou Nanxin Pharmaceutical Main Business
Table 195. Guangzhou Nanxin Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Cefuroxim Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cefuroxim Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cefuroxim Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cefuroxim Sales Market Share by Country/Region (2024)
Figure 8. Cefuroxim Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cefuroxim Market Size Market Share by Type in 2024
Figure 10. Cefuroxim in Respiratory Tract Infection
Figure 11. Global Cefuroxim Market: Respiratory Tract Infection (2020-2025) & ($ millions)
Figure 12. Cefuroxim in Otolaryngological Infection
Figure 13. Global Cefuroxim Market: Otolaryngological Infection (2020-2025) & ($ millions)
Figure 14. Cefuroxim in Urinary Tract Infection
Figure 15. Global Cefuroxim Market: Urinary Tract Infection (2020-2025) & ($ millions)
Figure 16. Cefuroxim in Skin And Soft Tissue Infections
Figure 17. Global Cefuroxim Market: Skin And Soft Tissue Infections (2020-2025) & ($ millions)
Figure 18. Cefuroxim in Bone And Joint Infections
Figure 19. Global Cefuroxim Market: Bone And Joint Infections (2020-2025) & ($ millions)
Figure 20. Cefuroxim in Gonorrhea
Figure 21. Global Cefuroxim Market: Gonorrhea (2020-2025) & ($ millions)
Figure 22. Cefuroxim in Other
Figure 23. Global Cefuroxim Market: Other (2020-2025) & ($ millions)
Figure 24. Global Cefuroxim Market Size Market Share by Application in 2024
Figure 25. Global Cefuroxim Revenue Market Share by Player in 2024
Figure 26. Global Cefuroxim Market Size Market Share by Region (2020-2025)
Figure 27. Americas Cefuroxim Market Size 2020-2025 ($ millions)
Figure 28. APAC Cefuroxim Market Size 2020-2025 ($ millions)
Figure 29. Europe Cefuroxim Market Size 2020-2025 ($ millions)
Figure 30. Middle East & Africa Cefuroxim Market Size 2020-2025 ($ millions)
Figure 31. Americas Cefuroxim Value Market Share by Country in 2024
Figure 32. United States Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 33. Canada Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 34. Mexico Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 35. Brazil Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 36. APAC Cefuroxim Market Size Market Share by Region in 2024
Figure 37. APAC Cefuroxim Market Size Market Share by Type (2020-2025)
Figure 38. APAC Cefuroxim Market Size Market Share by Application (2020-2025)
Figure 39. China Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 40. Japan Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 41. South Korea Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 42. Southeast Asia Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 43. India Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 44. Australia Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 45. Europe Cefuroxim Market Size Market Share by Country in 2024
Figure 46. Europe Cefuroxim Market Size Market Share by Type (2020-2025)
Figure 47. Europe Cefuroxim Market Size Market Share by Application (2020-2025)
Figure 48. Germany Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 49. France Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 50. UK Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 51. Italy Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 52. Russia Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 53. Middle East & Africa Cefuroxim Market Size Market Share by Region (2020-2025)
Figure 54. Middle East & Africa Cefuroxim Market Size Market Share by Type (2020-2025)
Figure 55. Middle East & Africa Cefuroxim Market Size Market Share by Application (2020-2025)
Figure 56. Egypt Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 57. South Africa Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 58. Israel Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 59. Turkey Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 60. GCC Countries Cefuroxim Market Size Growth 2020-2025 ($ millions)
Figure 61. Americas Cefuroxim Market Size 2026-2031 ($ millions)
Figure 62. APAC Cefuroxim Market Size 2026-2031 ($ millions)
Figure 63. Europe Cefuroxim Market Size 2026-2031 ($ millions)
Figure 64. Middle East & Africa Cefuroxim Market Size 2026-2031 ($ millions)
Figure 65. United States Cefuroxim Market Size 2026-2031 ($ millions)
Figure 66. Canada Cefuroxim Market Size 2026-2031 ($ millions)
Figure 67. Mexico Cefuroxim Market Size 2026-2031 ($ millions)
Figure 68. Brazil Cefuroxim Market Size 2026-2031 ($ millions)
Figure 69. China Cefuroxim Market Size 2026-2031 ($ millions)
Figure 70. Japan Cefuroxim Market Size 2026-2031 ($ millions)
Figure 71. Korea Cefuroxim Market Size 2026-2031 ($ millions)
Figure 72. Southeast Asia Cefuroxim Market Size 2026-2031 ($ millions)
Figure 73. India Cefuroxim Market Size 2026-2031 ($ millions)
Figure 74. Australia Cefuroxim Market Size 2026-2031 ($ millions)
Figure 75. Germany Cefuroxim Market Size 2026-2031 ($ millions)
Figure 76. France Cefuroxim Market Size 2026-2031 ($ millions)
Figure 77. UK Cefuroxim Market Size 2026-2031 ($ millions)
Figure 78. Italy Cefuroxim Market Size 2026-2031 ($ millions)
Figure 79. Russia Cefuroxim Market Size 2026-2031 ($ millions)
Figure 80. Egypt Cefuroxim Market Size 2026-2031 ($ millions)
Figure 81. South Africa Cefuroxim Market Size 2026-2031 ($ millions)
Figure 82. Israel Cefuroxim Market Size 2026-2031 ($ millions)
Figure 83. Turkey Cefuroxim Market Size 2026-2031 ($ millions)
Figure 84. Global Cefuroxim Market Size Market Share Forecast by Type (2026-2031)
Figure 85. Global Cefuroxim Market Size Market Share Forecast by Application (2026-2031)
Figure 86. GCC Countries Cefuroxim Market Size 2026-2031 ($ millions)


More Publications

Global Nasal Endoscopes Market Growth 2024-2030 US$ 3,660.00 December 2024 110 pages
Global Comfrey Root Market Growth 2024-2030 US$ 3,660.00 October 2024 96 pages